2313:HKEXShenzhou International Group Holdings Limited Analysis
Data as of 2026-08-15 - not real-time
NT$215.50
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Compeq Manufacturing Co., Ltd. is priced at TWD 215.50, and its moving averages give no clean directional read — the structure is neutral. Across the trailing 30 sessions it lost 6.1%. Relative strength is 52.1 — neutral — and the MACD signal is bullish. Recent trading has carved out support near TWD 154.00 and resistance around TWD 225.00.
The shares look fair, trading on 38.3 times earnings in line with a sector average of 36.5. Analyst price targets sit 46.6% above the current price. Revenue is growing at 9.8% on a 9.2% profit margin. The 1.31% dividend yield looks covered by current payout levels.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 95.3%, a beta of 0.99 and a maximum drawdown of 48.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 3/10 conviction on the long call.
The shares look fair, trading on 38.3 times earnings in line with a sector average of 36.5. Analyst price targets sit 46.6% above the current price. Revenue is growing at 9.8% on a 9.2% profit margin. The 1.31% dividend yield looks covered by current payout levels.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 95.3%, a beta of 0.99 and a maximum drawdown of 48.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 3/10 conviction on the long call.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Trading above the 200-day average of 185.64
- MACD momentum is positive
- 30-day price change of -6.1%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 38.3 versus sector average of 36.5
- Trading above the 200-day average of 185.64
- Analyst targets imply +46.6% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 38.3 versus sector average of 36.5
- Analyst targets imply +46.6% versus the current price
- Negative free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth9.80%
Profit Margin9.19%
P/E Ratio38.3
ROE16.54%
ROA5.99%
Debt/Equity37.01
P/B Ratio5.3
Op. Cash FlowNT$6.9B
Free Cash FlowNT$-111504000
Industry P/E36.5
Technical Analysis
TrendNeutral
RSI52.1
SupportNT$154.00
ResistanceNT$225.00
MA 20NT$200.10
MA 50NT$224.37
MA 200NT$185.64
MACDBullish
VolumeStable
Fear & Greed Index95.98
Valuation
Fair ValueNT$81.92
Target PriceNT$316.00
Upside/Downside46.64%
GradeFair
TypeGrowth
Dividend Yield1.31%
Risk Assessment
Beta0.99
Volatility95.35%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.